Ernest Pharmaceuticals

Ernest Pharmaceuticals has engineered a patented Bacterial Intracellular Delivery vector (BacID) that can produce and deliver biological drugs specifically to solid tumor cells. They have developed two bacterial therapies: 1) EBT-002 with a focus on heterogeneous tumors without biomarkers, such as liver cancer and 2) E

Ernest Pharmaceuticals operates in advanced therapies based in HADLEY, MA.

Profile

Ernest Pharmaceuticals has engineered a patented Bacterial Intracellular Delivery vector (BacID) that can produce and deliver biological drugs specifically to solid tumor cells. They have developed two bacterial therapies: 1) EBT-002 with a focus on heterogeneous tumors without biomarkers, such as liver cancer and 2) EBT-305, an immune strategy for ICI-resistant tumors. Both therapies are […]

Within the advanced therapies space, the company focuses on its core offering rather than a broad product line.

The company is recorded as being based in HADLEY, MA.

It is recorded at the SBIR Phase II stage.

Public records show total funding of about $1M.

Website: www.ernestpharma.com